Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Alexandre (Alex) Gaspar Maia, Ph.D., is the head of the Functional Epigenomics Laboratory at Mayo Clinic where he is combining some of the most advanced sequencing techniques to profile the epigenomic landscape at a single-cell level, primarily focusing on enhancer elements and transcriptional dependencies in ovarian cancer.
Dr. Maia has done extensive work in epigenetic regulation of stem cells, cellular reprogramming and cancer, and is interested in using epigenomic profiling of enhancer elements to decipher cellular heterogeneity, particularly to understand cancer stem cell states.
Advancing the current understanding of cancer stem cell states is extremely valuable for designing novel therapies and target transcriptional dependencies for each patient. This is ultimately the goal of personalized medicine.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Review my research fingerprint, network, grants, projects, publications, Scopus profile, and Altmetrics scores and badges.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.